A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa ; a preliminary report of efficacy
about
Phage therapy: concept to cureThe promise of bacteriophage therapy for Burkholderia cepacia complex respiratory infectionsAdvances in bacteriophage-mediated control of plant pathogensNatural solution to antibiotic resistance: bacteriophages 'The Living Drugs'Genetically Engineered Phages: a Review of Advances over the Last DecadeEcology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm BacteriaBacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current statusPhage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa InfectionsPhage cocktails and the future of phage therapyStructure of the bacteriophage T4 long tail fiber receptor-binding tipSynergistic action of gentamicin and bacteriophage in a continuous culture population of Staphylococcus aureusBacteriophages from ExPEC Reservoirs Kill Pandemic Multidrug-Resistant Strains of Clonal Group ST131 in Animal Models of BacteremiaMetaPhinder-Identifying Bacteriophage Sequences in Metagenomic Data SetsSynergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence.Phage therapy--constraints and possibilities.The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin Than by β-LactamsCharacterization of lytic enzyme open reading frame 9 (ORF9) derived from Enterococcus faecalis bacteriophage phiEF24C.Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections.Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and preventionPhenotypic and genotypic variations within a single bacteriophage species.Bacteriophages of Pseudomonas.Phage treatment of human infections.Comparative analysis of two phenotypically-similar but genomically-distinct Burkholderia cenocepacia-specific bacteriophages.Platforms for antibiotic discovery.Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad modelEvolution of Pseudomonas aeruginosa virulence as a result of phage predation.Genomic characterization of JG068, a novel virulent podovirus active against Burkholderia cenocepacia.Isolation and characterization of a "phiKMV-like" bacteriophage and its therapeutic effect on mink hemorrhagic pneumonia.Management of refractory Pseudomonas aeruginosa infection in cystic fibrosisGenomics, the origins of agriculture, and our changing microbe-scape: time to revisit some old tales and tell some new ones.Pseudomonas aeruginosa: resistance to the maxTargeting Enterococcus faecalis biofilms with phage therapy.Scaffold-based anti-infection strategies in bone repair.A window of opportunity to control the bacterial pathogen Pseudomonas aeruginosa combining antibiotics and phages.Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen.Characterization of the Newly Isolated Lytic Bacteriophages KTN6 and KT28 and Their Efficacy against Pseudomonas aeruginosa Biofilm.Enumeration of bacteriophage particles: Comparative analysis of the traditional plaque assay and real-time QPCR- and nanosight-based assaysThe isolation and characterization of two Stenotrophomonas maltophilia bacteriophages capable of cross-taxonomic order infectivity.Pseudomonas biofilms, cystic fibrosis, and phage: a silver lining?The Formulation of Bacteriophage in a Semi Solid Preparation for Control of Propionibacterium acnes Growth.
P2860
Q21131139-F0133806-42C8-416D-8DEF-01142EF1F4D8Q21131311-1A3F5248-F518-49EF-B3AF-0AF3F0B2C8CDQ21296665-8C8248F0-096A-4558-9346-9FA38169B2ACQ24563742-8E0C5A1A-13F0-4D6D-87BE-06B326B87E59Q26744156-4DB9177E-32C2-4452-AD06-242820BAFA01Q26786947-116E637B-BCAF-4BF3-A3EB-8B3719BF3535Q26799417-252EAA99-A1D5-4372-9172-C5E4C48A4720Q26823401-02074A3C-9298-441A-BDA5-C99E459FD3EAQ26995797-A51182F0-87F2-4AF7-8746-DEB3F4794B8FQ27665551-13F0B1FE-FB5F-41AF-804B-DC399D931929Q28485429-DE9D087B-FB70-4031-A388-2F6CF009CB3CQ30401003-A7F11712-A093-474B-BD8B-4A2E5E76E13DQ31133755-34F57B6D-B766-4BFE-A2F0-BF9EB4E1E057Q33553795-AAED4D26-988A-4CF0-872A-4B9EBF8E0FFAQ33667556-AAB20B9A-8EAF-4011-9756-CD4AE0B0DAB8Q33696025-F20D251C-0D85-40A1-B172-E5DC157925A7Q33753531-ED977FB3-FF60-4278-B8F6-B4193C6CE68DQ33798541-DAC37552-61C8-4219-BD0C-1B3C2446118DQ33828309-FB40D5C6-D99F-4BEB-9BED-2ED6FE4A905EQ33853311-14ECA1B8-3ED2-4B6B-A331-90C48D4BBE2EQ34126072-FCC9B411-4DFB-4EB0-A470-D288130F4571Q34254407-11B4D314-CBF5-4B18-8C79-C701D317403AQ34296269-0722E1DA-07BB-4901-BD4A-69595DAA4236Q34694926-1DC457F6-BD04-464D-8917-ABA0ED8F29C2Q34702499-7124E799-8BAD-4712-B137-B49F37A60163Q34871061-E85B1B1F-23C6-498E-B547-0C85C7543806Q34974472-43D95FEF-9FA3-46BE-A0C1-A7F6993C739DQ35007181-757E2F8A-E994-4337-98FE-B087CD3B408CQ35026630-EF9104EE-46EB-4F40-96A9-EB8D8C5F5B46Q35046422-36EB6477-AA2C-48B1-BFB8-E1D83A316B28Q35084559-CAA3AB77-11F3-4AD5-AD93-1070BB3107C7Q35221145-49DE89EC-7169-418C-B29A-C6EFD948606BQ35235414-6FBBFD0B-AC8C-4226-B71E-65EAE977D0ADQ35279671-85E01BF8-9B73-45D2-AA77-9005697E6BEFQ35458523-0683C1E1-B62A-4239-B360-EDE9006FF706Q35634231-4C8DB752-5B69-4C74-B5CD-FABDB6D8D968Q35754471-D32946B3-0CDA-495C-9CD3-072E6D7F5862Q35763512-CD98C7FB-345E-44DB-B06B-EE4FFBFAE4B3Q35878716-7A1153B1-40C8-4931-930C-E264138C75C3Q35952871-1DC25447-32AD-496F-A73C-A940CE9E1BCD
P2860
A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa ; a preliminary report of efficacy
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A controlled clinical trial of ...... preliminary report of efficacy
@ast
A controlled clinical trial of ...... preliminary report of efficacy
@en
A controlled clinical trial of ...... preliminary report of efficacy
@en-gb
A controlled clinical trial of ...... preliminary report of efficacy
@nl
type
label
A controlled clinical trial of ...... preliminary report of efficacy
@ast
A controlled clinical trial of ...... preliminary report of efficacy
@en
A controlled clinical trial of ...... preliminary report of efficacy
@en-gb
A controlled clinical trial of ...... preliminary report of efficacy
@nl
altLabel
A controlled clinical trial of ...... preliminary report of efficacy
@en
prefLabel
A controlled clinical trial of ...... preliminary report of efficacy
@ast
A controlled clinical trial of ...... preliminary report of efficacy
@en
A controlled clinical trial of ...... preliminary report of efficacy
@en-gb
A controlled clinical trial of ...... preliminary report of efficacy
@nl
P2093
P921
P3181
P1476
A controlled clinical trial of ...... preliminary report of efficacy
@en
P2093
C.H. Hawkins
D.R. Harper
E.E. Änggård
P304
P3181
P356
10.1111/J.1749-4486.2009.01973.X
P407
P577
2009-08-01T00:00:00Z